Zimbabwe has rejected a significant US healthcare agreement worth 367 million US dollars (£272m) spanning five years due to Washington's request for confidential biological samples.
The decision was revealed after a government memo from December was leaked, which showed Head of State Emmerson Mnangagwa deemed the deal was "unbalanced".
A government spokesperson has since clarified that the United States was demanding access to genetic material for research and profit while refused to share the resulting advantages from future medical innovations.
"We must now begin the difficult and regrettable task of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for further talks to reach a agreement suitable to all parties so the nation's vital HIV programme can proceed.
Wider Implications
Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a high court suspended a similar deal with the US after concerns were raised about the security of Kenyans' medical information.
Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump stated its spending was "wasteful" and his administration was seeking government-to-government agreements to enhance transparency and responsibility.
As per reports, Sixteen nations in Africa have to date signed these new health pacts, constituting over $18.3bn in new funding.
Specifics of the Declined Deal
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration would have delivered significant advantages for the people of Zimbabwe, especially the 1.2 million presently receiving antiretroviral therapy via US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to share its biological resources and data indefinitely, without any equivalent guarantee of access to any medical innovations – such as new medicines or tests – that could be developed from that provided information," he stated.
"Effectively, our nation would supply the basic resources for medical research without any certainty that the final treatments would be accessible to our people if a new pandemic arise."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were upending frameworks already set up via the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to manage potential pandemics.
"This mechanism is intended to guarantee that when a nation provides its information, the benefits – such as medicines and cures – are shared equitably, not monopolised solely by those with the capability to create them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," he added.
"We are open to ongoing discussions with our American counterparts on how subsequent co-operation could be arranged in a way that honours the independence and interests of both nations."
Medical Community Reaction
A leading public health body stated it understood the official position, but urged that talks need to persist since much of the country's HIV programmes were funded by external financing.
"In cases where specific concerns exist, such as those involving information security or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," it added.
The halted deal underscores the ongoing tensions between accepting much-needed international aid and protecting local interests in an ever more interconnected world.